These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 39229496)
1. PTOV1 facilitates colorectal cancer cell proliferation through activating AKT1 signaling pathway. Xie SA; Zhang W; Du F; Liu S; Ning TT; Zhang N; Zhang ST; Zhu ST Heliyon; 2024 Aug; 10(16):e36017. PubMed ID: 39229496 [TBL] [Abstract][Full Text] [Related]
2. Depleting PTOV1 sensitizes non-small cell lung cancer cells to chemotherapy through attenuating cancer stem cell traits. Wu Z; Liu Z; Jiang X; Mi Z; Meng M; Wang H; Zhao J; Zheng B; Yuan Z J Exp Clin Cancer Res; 2019 Aug; 38(1):341. PubMed ID: 31387622 [TBL] [Abstract][Full Text] [Related]
3. LncRNA PTOV1-AS2 Promotes Colon Cancer Progression through the miR-145-5p/FSCN1 Axis. Zhang Z; Wu H; Chen Z; Li G; Guo J J Oncol; 2023; 2023():1298312. PubMed ID: 36960218 [TBL] [Abstract][Full Text] [Related]
4. PSAT1 mediated EMT of colorectal cancer cells by regulating Pl3K/AKT signaling pathway. Wang M; Zhang H; Lu Z; Su W; Tan Y; Wang J; Jia X J Cancer; 2024; 15(10):3183-3198. PubMed ID: 38706897 [No Abstract] [Full Text] [Related]
5. Pan-cancer analysis confirms the prognostic and immunological effects of prostate tumor overexpressed-1 in human cancers. Liu F; Li Z; Wan S; Li Y; Ye Z; Li D Curr Cancer Drug Targets; 2023 Mar; ():. PubMed ID: 36927431 [TBL] [Abstract][Full Text] [Related]
6. KIFC3 Promotes Proliferation, Migration, and Invasion in Colorectal Cancer Liao H; Zhang L; Lu S; Li W; Dong W Front Genet; 2022; 13():848926. PubMed ID: 35812733 [No Abstract] [Full Text] [Related]
7. Prostate tumor OVerexpressed-1 (PTOV1) down-regulates HES1 and HEY1 notch targets genes and promotes prostate cancer progression. Alaña L; Sesé M; Cánovas V; Punyal Y; Fernández Y; Abasolo I; de Torres I; Ruiz C; Espinosa L; Bigas A; Y Cajal SR; Fernández PL; Serras F; Corominas M; Thomson TM; Paciucci R Mol Cancer; 2014 Mar; 13():74. PubMed ID: 24684754 [TBL] [Abstract][Full Text] [Related]
8. High expression of prostate tumor overexpressed 1 (PTOV1) is a potential prognostic biomarker for cervical cancer. Chen Y; Hu Z; Chai D Int J Clin Exp Pathol; 2017; 10(11):11044-11050. PubMed ID: 31966450 [TBL] [Abstract][Full Text] [Related]
9. Colorectal cancer with low SLC35A3 is associated with immune infiltrates and poor prognosis. Lu S; Sun X; Tang H; Yu J; Wang B; Xiao R; Qu J; Sun F; Deng Z; Li C; Yang P; Yang Z; Rao B Sci Rep; 2024 Jan; 14(1):329. PubMed ID: 38172565 [TBL] [Abstract][Full Text] [Related]
10. Knockdown of PTOV1 and PIN1 exhibit common phenotypic anti-cancer effects in MDA-MB-231 cells. Karna SKL; Ahmad F; Lone BA; Pokharel YR PLoS One; 2019; 14(5):e0211658. PubMed ID: 31083670 [TBL] [Abstract][Full Text] [Related]
11. Downregulation of CPT2 promotes proliferation and inhibits apoptosis through p53 pathway in colorectal cancer. Liu F; Li X; Yan H; Wu J; Yang Y; He J; Chen J; Jiang Z; Wu F; Jiang Z Cell Signal; 2022 Apr; 92():110267. PubMed ID: 35108639 [TBL] [Abstract][Full Text] [Related]
12. LncRNA SNHG6 promotes proliferation, invasion and migration in colorectal cancer cells by activating TGF-β/Smad signaling pathway via targeting UPF1 and inducing EMT via regulation of ZEB1. Wang X; Lai Q; He J; Li Q; Ding J; Lan Z; Gu C; Yan Q; Fang Y; Zhao X; Liu S Int J Med Sci; 2019; 16(1):51-59. PubMed ID: 30662328 [No Abstract] [Full Text] [Related]
13. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway. Lin F; Zhang G; Yang X; Wang M; Wang R; Wan M; Wang J; Wu B; Yan T; Jia Y J Ethnopharmacol; 2023 Mar; 303():115933. PubMed ID: 36403742 [TBL] [Abstract][Full Text] [Related]
14. LncRNA AB073614 regulates proliferation and metastasis of colorectal cancer cells via the PI3K/AKT signaling pathway. Wang Y; Kuang H; Xue J; Liao L; Yin F; Zhou X Biomed Pharmacother; 2017 Sep; 93():1230-1237. PubMed ID: 28738539 [TBL] [Abstract][Full Text] [Related]
15. ARHGAP9 inhibits colorectal cancer cell proliferation, invasion and EMT via targeting PI3K/AKT/mTOR signaling pathway. Sun J; Zhao X; Jiang H; Yang T; Li D; Yang X; Jia A; Ma Y; Qian Z Tissue Cell; 2022 Aug; 77():101817. PubMed ID: 35679685 [TBL] [Abstract][Full Text] [Related]
16. miR-422a inhibits cell proliferation in colorectal cancer by targeting AKT1 and MAPK1. Wei WT; Nian XX; Wang SY; Jiao HL; Wang YX; Xiao ZY; Yang RW; Ding YQ; Ye YP; Liao WT Cancer Cell Int; 2017; 17():91. PubMed ID: 29118671 [TBL] [Abstract][Full Text] [Related]
17. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer. Chi M; Liu J; Mei C; Shi Y; Liu N; Jiang X; Liu C; Xue N; Hong H; Xie J; Sun X; Yin B; Meng X; Wang B J Exp Clin Cancer Res; 2022 May; 41(1):175. PubMed ID: 35581606 [TBL] [Abstract][Full Text] [Related]
18. lncRNA KCNQ1OT1 knockdown inhibits colorectal cancer cell proliferation, migration and invasiveness via the PI3K/AKT pathway. Duan Q; Cai L; Zheng K; Cui C; Huang R; Zheng Z; Xie L; Wu C; Yu X; Yu J Oncol Lett; 2020 Jul; 20(1):601-610. PubMed ID: 32565985 [TBL] [Abstract][Full Text] [Related]
19. Downregulation of GLYR1 contributes to microsatellite instability colorectal cancer by targeting p21 via the p38MAPK and PI3K/AKT pathways. Hu Z; Long T; Ma Y; Zhu J; Gao L; Zhong Y; Wang X; Wang X; Li Z J Exp Clin Cancer Res; 2020 May; 39(1):76. PubMed ID: 32370786 [TBL] [Abstract][Full Text] [Related]
20. Integrated profiling identifies DXS253E as a potential prognostic marker in colorectal cancer. Xing P; Hao H; Chen J; Qiao X; Song T; Yang X; Weng K; Hou Y; Chen J; Wang Z; Di J; Jiang B; Xing J; Su X Cancer Cell Int; 2024 Jun; 24(1):213. PubMed ID: 38890691 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]